![](/img/cover-not-exists.png)
PRETARGET® RADIOIMMUNOTHERAPY (RIT) WITH A FUSION PROTEIN: PHARMACOKINETIC RESULTS FROM A DOSE OPTIMIZATION STUDY.
Forero-Torres, A, Shen, S, LoBuglio, A, Percent, I, Besch, S, Breitz, H, Sims, R, Meredith, RVolume:
52
Journal:
Journal of Investigative Medicine
DOI:
10.1097/00042871-200401001-00759
Date:
January, 2004
File:
PDF, 1.96 MB
2004